Trial intelligence / Profile preview

Avastin with Carboplatin and Paclitaxel in Endometrial Cancer

NCT00879359Phase 2Completed

Sponsor
Cleveland Clinic
Start
Dec 2007
Primary completion
Feb 2012
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 2 trial of bevacizumab in endometrial carcinoma, sponsored by Cleveland Clinic. Started Dec 2007; status: completed.

02

Drugs

bevacizumab
03

Conditions

endometrial carcinoma

Beyond the preview

Go deeper on NCT00879359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00879359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call